play tumblr googleplus facebook twitter youtube vimeo linkedin instagram
I live inside the U.S. Outside the U.S.
In the European Union, the Lumee™ Oxygen Platform is CE Marked. In the United States, the Lumee Oxygen Platform is an Investigational Device Limited by Federal Law to Investigational Use.

Profusa is pioneering tissue-integrating biosensors for continuous monitoring of body chemistries.

News & Events

DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict ...

New Insights Come as Profusa Receives CE Mark for Its Latest Generation Device, the Wireless Lumee® Oxygen Platform ...

Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future EMERYVILLE, Calif., [January 28, 2020] ...

Awarded 2018 Entrepreneurial Company of the Year for real-time body chemistry monitoring South San Francisco, Calif. – October ...

Profusa Software and Systems Lead, Kevin Zhao, has been selected to participate in the Defense Advanced Research Projects ...

Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors ...

Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia.

NEW ORLEANS, March 19, 2018 — Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented ...